BioGaia AB (publ) (BIOG-B) - Total Liabilities
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has total liabilities worth Skr235.14 Million SEK (≈ $25.30 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BIOG-B strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
BioGaia AB (publ) - Total Liabilities Trend (2002–2025)
This chart illustrates how BioGaia AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see BioGaia AB (publ) assets under control.
BioGaia AB (publ) Competitors by Total Liabilities
The table below lists competitors of BioGaia AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ITMAX System Berhad
KLSE:5309
|
Malaysia | RM140.04 Million |
|
Atresmedia Corporación de Medios de Comunicación S.A.
MC:A3M
|
Spain | €730.78 Million |
|
Aurisco Pharmaceutical Co Ltd
SHG:605116
|
China | CN¥1.47 Billion |
|
El Puerto de Liverpool S.A.B. de C.V
MX:LIVEPOLC-1
|
Mexico | MX$124.59 Billion |
|
Terveystalo Oy
HE:TTALO
|
Finland | €854.50 Million |
|
Mahanagar Gas Limited
NSE:MGL
|
India | Rs-64.42 Billion |
|
CHIPMOS TECH.ADR 20 TA10
F:CPIA
|
Germany | €21.37 Billion |
|
Goldsun Building Materials Co Ltd
TW:2504
|
Taiwan | NT$23.15 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down BioGaia AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BioGaia AB (publ) balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioGaia AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioGaia AB (publ) (2002–2025)
The table below shows the annual total liabilities of BioGaia AB (publ) from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr283.59 Million ≈ $30.52 Million |
-8.54% |
| 2024-12-31 | Skr310.07 Million ≈ $33.37 Million |
+1.48% |
| 2023-12-31 | Skr305.54 Million ≈ $32.88 Million |
+26.49% |
| 2022-12-31 | Skr241.55 Million ≈ $25.99 Million |
-3.65% |
| 2021-12-31 | Skr250.69 Million ≈ $26.98 Million |
+50.08% |
| 2020-12-31 | Skr167.04 Million ≈ $17.98 Million |
+5.70% |
| 2019-12-31 | Skr158.03 Million ≈ $17.01 Million |
+4.07% |
| 2018-12-31 | Skr151.85 Million ≈ $16.34 Million |
+35.31% |
| 2017-12-31 | Skr112.22 Million ≈ $12.08 Million |
+52.07% |
| 2016-12-31 | Skr73.80 Million ≈ $7.94 Million |
-4.59% |
| 2015-12-31 | Skr77.34 Million ≈ $8.32 Million |
+8.91% |
| 2014-12-31 | Skr71.02 Million ≈ $7.64 Million |
+6.69% |
| 2013-12-31 | Skr66.56 Million ≈ $7.16 Million |
+10.52% |
| 2012-12-31 | Skr60.23 Million ≈ $6.48 Million |
+21.73% |
| 2011-12-31 | Skr49.48 Million ≈ $5.32 Million |
+22.17% |
| 2010-12-31 | Skr40.50 Million ≈ $4.36 Million |
+116.62% |
| 2009-12-31 | Skr18.70 Million ≈ $2.01 Million |
-14.58% |
| 2008-12-31 | Skr21.89 Million ≈ $2.36 Million |
+37.97% |
| 2007-12-31 | Skr15.86 Million ≈ $1.71 Million |
-2.28% |
| 2006-12-31 | Skr16.23 Million ≈ $1.75 Million |
+5.59% |
| 2005-12-31 | Skr15.37 Million ≈ $1.65 Million |
-9.60% |
| 2004-12-31 | Skr17.01 Million ≈ $1.83 Million |
-19.23% |
| 2003-12-31 | Skr21.05 Million ≈ $2.27 Million |
-37.41% |
| 2002-12-31 | Skr33.64 Million ≈ $3.62 Million |
-- |
About BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more